Method for the inhibition of the replication of DNA viruses with

Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

536 23, 536 29, 424 89, A61K 3170, A61K 39245

Patent

active

044683847

ABSTRACT:
A method for inhibiting the replication of a DNA virus which induces formation of thymidine kinase enzyme, by exposing the virus to an effective concentration of a compound of the formula: ##STR1## wherein R.sub.1 is a radical selected from the group consisting of halogen, --SCH.sub.3, --OH, alkoxy, cyano, methylamino, carboxy, formyl, nitro and unsubstituted or halosubstituted hydrocarbon groups of 1 through 3 carbon atoms; R.sub.2 is hydrogen; halogen or hydroxy; and R.sub.3 is hydroxy, --OP(O)(OH).sub.2, amino, or --OOR.sub.4 where R.sub.4 is lower alkyl of 1 through 6 carbon atoms.

REFERENCES:
Schroeder, A., "Synthesis of New Nucleoside Analogs Derived From 4-Deoxyuracil and 6-Substituted Uracils", A dissertation Submitted to the Faculty of the Graduate School, State University of New York, 1978.
Cheng, Y. et al., Antimicrobial Agents and Chemotherapy, vol. 10, pp. 119-122, 1976.
Rada, B. et al., Chemotherapy, vol. 20, pp. 141-147, 1974.
Chemical Abstracts, vol. 93, p. 706, Abstract No. 186752v, 1980.
Chemical Abstracts, vol. 81, p. 70, Abstract No. 146282n, 1974.
Chemical Abstracts, vol. 79, p. 136, Abstract No. 144106t, 1973.
Chemical Abstracts, vol. 71, p. 36602c, Abstract No. 36602c, 1969.
Schroeder et al., J. Med. Chem., vol. 24, pp. 109-112, 1980.
Cheng, Y., Federation of European Biochemical Societies Symposia, vol. 57, pp. 263-273, 1978.
De Clercq, E. et al., Federation of European Biochemical Societies Symposia, vol. 57, pp. 275-285, 1978.
Prusoff, W., Federation of European Biochemical Societies Symposia, vol. 57, pp. 287-293, 1978.
Oyen et al., "5-Fluoropyrimidin-2-one Deoxyriboside and its Growth-Inhibiting Properties", Biochim. Biophys. Acta, 182 (1969), pp. 567-569.
Votruba, I. et al., "Mechanism of Inhibition of DNA Synthesis in Escherichia coli by Pyrimidin-2-one .beta.-D-Ribofuranoside", Biochimica et Biophysica Acta, 324 (1973), pp. 14-23.
Laland, S. G. et al., "Synthesis of Pyrimidin-2-one Deoxyribosides and their Ability to Support the Growth of the Deoxyriboside-Requiring Organism Lactobacillus acidophilus R26", Biochem. Journal, 90 (1964), pp. 76-81.
Oyen, T. B., "Synthesis and Properties of Ribosylpyrimidin-2-One", Biochimica et Biophysica Acta, 186 (1969), pp. 237-243.
Oftebro, R. et al., "5-Fluoropyrimidin-2-one, A New Metaphase Arresting Agent", Biochemical Pharmacology, 21 (1972), pp. 2451-2456.
McCormack et al., "Inhibition of Cytidine Deaminase by 2-oxopyrimidine Riboside and Related Compounds", Biochemical Pharmacology, 29 (1980), pp. 830-832.
Torrence, P. F. et al., "Synthesis and Antiviral Activities of New 5-Substituted Pyrimidine Nucleoside Analogs", Frontiers in Bioorganic Chemistry and Molecular Biology, (1979), pp. 59-85.
Johns et al., "Enzymic Hydroxylation of 5-Fluoropyrimidines by Aldehyde Oxidase and Xanthine Oxidase", Biochemical Pharmacology, 15 (1966), pp. 400-403.
Prusoff, W. H. et al., "Antiviral Iodinated Pyrimidine Deoxyribonucleosides: 5-IODO-2'-Deoxyuridine; 5 IODO-2'-Deoxycytidine; 5-IODO-5'-Amino-2',5'-Dideoxyuridine", Pharmaceutical Therapy, 7 (1979), pp. 1-34.
Renis, H. E., "Pyrimidines and Their Nucleosides", Antibiotics Chemotherapy, 27 (1980), pp. 164-207.
Wightman, R. et al., "Nucleic Acid Components and Their Analogues Clix. Synthesis of Some 2-Pyrimidone Nucleosides", Collection of Czechoslov. Chemical Communications, 38 (1973), pp. 1381-1397.
Kohler, P. et al., "Anomeric (1-(2-Deoxy-D-Erythro-Pentofuranosyl)-2(1H)-Pyrimidinones, Nucleic Acid Chemistry, John Wiley & Sons, N.Y. (1978), pp. 283-289.
Johns, D. G., "Human Liver Aldehyde Oxidase: Differential Inhibition of Oxidation of Charged and Uncharged Substrates", Journal of Clinical Investigation, 46 (1967), No. 9, pp. 1492-1505.
Helgeland et al., "The Synthesis, Characterization and Biological Properties of a New Substance, 5-Fluoropyrimidin-2-one", Biochim. Biophys. Acta, 87 (1964), pp. 353-355.
Oyen, T. B. et al., "Preparation and Biological Properties of Deoxyribosides and Deoxyribotides of Pyrimidin-2-one", Biochem. Journal 92 (1964), pp. 27P-28P.
Doskocil et al., "Inhibition of Nucleoside-Binding Sites by Nucleoside Analogues in Escherichia coli", Nucleic Acids Research, (1974), pp. 491-502.
Cheng et al., "Properties of Herpesvirus-Specific Thymidine Kinase, DNA Polymerase and DNase and Their Implication in the Development of Specific Antiherpes Agents", Advances in Ophthalmalogy, 38 (1979), pp. 183-186.
Prusoff et al., "Role of Nucleosides in Virus and Cancer Chemotherapy", Advances in Opthalmalogy, 38 (1079), pp. 3-16.
Nakayama, C. et al., "Synthetic Nucleosides and Nucleotides. XII..sup.1 Synthesis and Antiviral Activities of Several 1-.beta.-D-Arabinofuranosyl-5-Alkyluracils and Their Monophosphates", Carbohydrates-Nucleosides-Nucleotides, Marcel Dekker, Inc., 6(4), pp. 295-308.
Sakata, S. et al., "Synthesis and Antiherpesviral Activity of 5-C-Substituted Uracil Nucleosides", Nucleic Acids Research, 8 (1980), pp. 39-42.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for the inhibition of the replication of DNA viruses with does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for the inhibition of the replication of DNA viruses with, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the inhibition of the replication of DNA viruses with will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-877097

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.